Aaron Rosenberg is an Oncology physician affiliated with University of California Davis Medical Center. OpenAlex indexes 153 publications with 3,192 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4501 X St Ste 3016
Sacramento, CA 958172229
Telephone
916-734-5981Registry record last updated 26 Sept 2019.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- Janssen Biotech, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
26.5%Thalidomide Analog8.9%Revlimid45%Lenalidomide28%Pomalyst28%Part D<11 patientsLeukocyte Growth Factor5.1%Zarxio100%Part D≥16 patients+ 4 more classes in this area
Dermatology
20.2%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor20.2%Acyclovir100%Part D≥39 patientsSensory organs
15.9%Corticosteroid15.9%Dexamethasone100%Part D≥32 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025
Journal of the National Comprehensive Cancer Network
2025 - Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2024 - Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States
The Journal of Prevention of Alzheimer s Disease
2024 - Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Helen Chew, MD
University of California Davis Medical Center
Ai‐Ming Yu
University of California Davis Medical Center
Burton L. Wise
University of California Davis Medical Center
Courtney Wusthoff, MD
University of California Davis Medical Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”